Latest 10-Q quarterly reports

CareTrust REIT's Q2 2026 filing shows significant revenue increases driven by acquisitions and investments, alongside a rise in expenses and a new provision for loan losses.

Xeris Biopharma Holdings, Inc. announced a 33.1% increase in total revenue for the six months ended June 30, 2026, driven by significant growth in Recorlev, though a substantial loss on debt extinguishment impacted net results.

Wheeler Real Estate Investment Trust, Inc. (WHLR) filed its Form 10-Q for the quarter ended June 30, 2026, reporting a decrease in total revenue and an increase in operating expenses, alongside significant impairment charges.

Nerdy Inc. announced its second-quarter 2026 financial results, showing a decrease in revenue and an increase in operating loss, alongside strategic decisions to wind down certain business operations.

INmune Bio's Q2 2026 report reveals a significant decrease in R&D expenses and raises substantial doubt about its ability to continue as a going concern, despite progress on regulatory submissions for CORDStrom.

Revelation Biosciences reported increased operating expenses and net losses for the six months ended June 30, 2026, raising substantial doubt about its ability to continue as a going concern and facing potential Nasdaq delisting.

Americold Realty Trust, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting a substantial net loss driven by significant asset impairments, while also detailing operational performance across its Warehouse and Transportation segments.

Payoneer Global Inc. reported a net loss of $2.4 million for Q2 2026, a significant downturn from the prior year's profit, while revenue increased by 5% to $274.3 million.

National Healthcare Properties, Inc. reported improved SHOP segment performance and significant capital infusion from a public offering, alongside strategic debt management and property dispositions.

Roman DBDR Acquisition Corp. II reports on its financial status as of June 30, 2026, detailing its progress towards a business combination with ThomasLloyd.

MACOM Technology Solutions Holdings, Inc. announced a significant increase in revenue and gross profit for the third quarter of fiscal year 2026, driven by strong performance in its Data Center and Industrial & Defense segments.

Power Integrations, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting an increase in net revenue and net income compared to the same period in the previous year.

Magnolia Oil & Gas Corporation announced robust financial results for the second quarter of 2026, driven by increased oil prices and production, and revealed a significant acquisition expected to enhance its market position.

Aldeyra Therapeutics reported a reduced net loss for the quarter ended June 30, 2026, driven by lower research and development expenses, but also disclosed a new Complete Response Letter from the FDA regarding its reproxalap New Drug Application.

Mach Natural Resources LP announced significant revenue and production increases for the second quarter of 2026, driven by strategic acquisitions and expanded operations.

Indigo Acquisition Corp. reports on its financial status for the quarter ended June 30, 2026, highlighting interest income and ongoing efforts to secure a business combination before its deadline.

Research Frontiers Inc. reported its Q2 2026 results, showing a net loss and facing continued challenges with Nasdaq listing requirements, though a recent capital raise provided some liquidity.

Clipper Realty Inc. disclosed a widening net loss for the second quarter of 2026, primarily driven by commercial rental income decline and significant interest expenses related to property defaults.

Interactive Brokers Group, Inc. announced a significant increase in net revenues and net income for the second quarter of 2026, driven by higher customer trading volumes and net interest income.

Voyager Therapeutics' Q2 2026 Form 10-Q details progress in neurological disease programs, including VY1706 and VY7523, alongside collaborations with Novartis and Neurocrine, while managing operational expenses and cash runway.

Gogo Inc. reported a slight decrease in total revenue for Q2 2026, alongside a continued material weakness in internal controls, though operational metrics show mixed results.

ALX Oncology Holdings Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing continued net losses but a strengthened cash position following recent equity raises.

EPAM Systems announced a 6.0% increase in revenue for the first six months of 2026, reaching $2.815 billion, driven by improving demand and foreign exchange fluctuations, alongside a notable improvement in operating income margin.

Siddhi Acquisition Corp reports on its financial condition for Q2 2026, highlighting its status as a SPAC with substantial trust account assets but no operating revenue, and facing a looming liquidation deadline.

KVH Industries saw a 27% increase in net sales for the six months ended June 30, 2026, driven by LEO services, though costs also rose, impacting operational cash flow.

Viasat, Inc. reported a net loss of $51.7 million for the first quarter of fiscal year 2027, with total revenues decreasing by 1% to $1.16 billion.

ATI Inc. announced a significant increase in sales and net income for the second quarter of 2026, driven by robust demand in its core aerospace and defense markets.

Illinois Tool Works Inc. announced robust financial results for the second quarter and year-to-date 2026, demonstrating significant growth in operating revenue and income, alongside improved margins.

German American Bancorp, Inc. announced a significant increase in net income and earnings per share for the second quarter and first half of 2026, driven by improved net interest income and non-interest income.

MKS Inc. announced robust Q2 2026 results, showcasing significant revenue increases across key markets and improved gross margins, alongside strategic debt reduction.